Oramed Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Oramed Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Israel
- Ticker symbol
- ORMP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001176309
Board of directors
-
Arie Mayer · DirectorSince 2023
-
Benjamin Shapiro · DirectorSince 2023
-
Daniel Aghion · DirectorSince 2024
-
Leonard Sank · DirectorSince 2023
-
Miriam Kidron · Director · Chief Scientific OfficerSince 2023
-
Nadav Kidron · Director · President and CEOSince 2023
-
Yadin Rozov · DirectorSince 2023
Chief executives
Nadav Kidron
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 2 other boards.
- via Yadin Rozov
- via Yadin Rozov
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 26, 2023 | Nadav Kidron Director, Officer (President and CEO) | Grant or award | +120,000 | — | — |
| May 26, 2023 | Derovan Netanel Officer (Chief Legal Officer) | Grant or award | +20,500 | — | — |
| May 26, 2023 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Grant or award | +53,500 | — | — |
| May 26, 2023 | Hexter Joshua Officer (COO & CBO) | Grant or award | +27,000 | — | — |
| May 26, 2023 | Silberman David Officer (Chief Financial Officer) | Grant or award | +24,500 | — | — |
| May 1, 2023 | Benjamin Shapiro Director | Grant or award | +20,000 | — | — |
| Apr 17, 2023 | Leonard Sank Director | Grant or award | +30,000 | — | — |
| Apr 17, 2023 | Derovan Netanel Officer (Chief Legal Officer) | Grant or award | +81,000 | — | — |
| Apr 17, 2023 | Hexter Joshua Officer (COO & CBO) | Grant or award | +108,000 | — | — |
| Apr 17, 2023 | Nadav Kidron Director, Officer (President and CEO) | Grant or award | +279,000 | — | — |
| Apr 17, 2023 | Yadin Rozov Director | Grant or award | +30,000 | — | — |
| Apr 17, 2023 | Miriam Kidron Director, Officer (Chief Scientific Officer) | Grant or award | +213,000 | — | — |
| Apr 17, 2023 | Silberman David Officer (Chief Financial Officer) | Grant or award | +97,500 | — | — |
| Apr 17, 2023 | Arie Mayer Director | Grant or award | +30,000 | — | — |
| Apr 4, 2023 | Arie Mayer Director | Open-market purchase | +3,800 | $2.21 | $8,398 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.